Management of anemia associated with myelodysplastic syndrome.
Hellström-Lindberg
E
E
Department of Medicine, Huddinge Hospital, Division of Hematology, Huddinge, Sweden. hellstrom-lindberg@medhs.ki.se
D000740:Anemia / Q000209:etiology / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008954:Models, Biological; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000175:diagnosis; D011379:Prognosis; D013792:Thalidomide / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D013792:Thalidomide